Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1971 2
1972 3
1973 6
1974 3
1975 2
1976 1
1977 6
1978 3
1979 1
1980 1
1982 1
1985 1
1987 1
1988 3
1989 1
1991 1
1992 1
1993 1
1997 1
1998 1
1999 1
2000 3
2001 2
2002 2
2003 3
2004 4
2005 1
2007 1
2008 2
2015 1
2020 1
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

61 results
Results by year
Filters applied: . Clear all
Page 1
Clinical applications of MAO-inhibitors.
Riederer P, Lachenmayer L, Laux G. Riederer P, et al. Among authors: lachenmayer l. Curr Med Chem. 2004 Aug;11(15):2033-43. doi: 10.2174/0929867043364775. Curr Med Chem. 2004. PMID: 15279566 Review.
Serotonin neurotoxins--past and present.
Baumgarten HG, Lachenmayer L. Baumgarten HG, et al. Among authors: lachenmayer l. Neurotox Res. 2004;6(7-8):589-614. doi: 10.1007/BF03033455. Neurotox Res. 2004. PMID: 15639791 Review.
[The parathymic syndromes].
Janzen RW, Lachenmayer L. Janzen RW, et al. Among authors: lachenmayer l. Dtsch Med Wochenschr. 1976 Aug 27;101(35):1292-4. doi: 10.1055/s-0028-1104259. Dtsch Med Wochenschr. 1976. PMID: 954580 German. No abstract available.
Which factors influence therapeutic decisions in Parkinson's disease?
Baas H, Fuchs G, Gemende I, Hueber R, Lachenmayer L, Schneider E, Schoenberger B, Werner M. Baas H, et al. Among authors: lachenmayer l. J Neurol. 2002 Oct;249 Suppl 3:III/49-52. doi: 10.1007/s00415-002-1310-3. J Neurol. 2002. PMID: 12522573 Review.
Selegiline's neuroprotective capacity revisited.
Riederer P, Lachenmayer L. Riederer P, et al. Among authors: lachenmayer l. J Neural Transm (Vienna). 2003 Nov;110(11):1273-8. doi: 10.1007/s00702-003-0083-x. J Neural Transm (Vienna). 2003. PMID: 14628191 No abstract available.
61 results